Publications

Export 17 results:
Sort by: Author Title Type [ Year  (Desc)]
2022
Kamel, A. M., N. A. H. L. A. M.ELSHARKAWY, Eman Z. Kandeel, M. Hanafi, M. Samra, and R. A. Osman, "Leukemia Stem Cell Frequency at Diagnosis Correlates With Measurable/Minimal Residual Disease and Impacts Survival in Adult Acute Myeloid Leukemia", Frontiers in Oncology , vol. 12, pp. 867684-867684, 2022.
2021
Kandeel, E. Z., L. Refaat, R. Abdel-Fatah, M. Samra, A. Bayoumi, M. S. Abdellateif, H. Abdel-Hady, M. Ali, and medhat khafagy, ""Could COVID-19 induce remission of acute leukemia?.3.", Hematology, vol. 26, issue 1, pp. 870-873., 2021.
kandeel e, Y. madney, Dalia Negm Eldin, and N. F. Shafik, "Overexpression of CD200 and CD123 is a major influential factor in the clinical course of pediatric acute myeloid leukemia", Experimental and Molecular Pathology, vol. 118 (2021): 104597., pp. 104597., 2021.
Maha, S., M. Khali, M. S. Abdellateif, E. Ebeid, Y. madney, and E. Z. Kandeel, "Role of matrix metalloproteinase MMP-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP-1) in the clinical progression of pediatric acute lymphoblastic leukemia", Hematology, vol. 26, issue 1, pp. 758-768., 2021.
2020
kandeel e, E. N, H. M, S. M, and kamel A, "Tracing Leukemia Stem Cells and Their Influence on Clinical Course of Adult Acute Myeloid Leukemia", Clin Lymphoma Myeloma Leuk, vol. Jun;2020, issue 6, pp. 383-393, 2020.
2019
kandeel, E., Y. Madney, R. Amin, and A. Kamel, "Role of Minimal Residual Disease in the Clinical Course of T cell Acute Lymphoblastic Leukemia in Pediatric Patients", J Leuk 7 , vol. 7, pp. 256., 2019.
kandeel, E., Y. Madney, R. Amin, and A. Kamel, "Role of Minimal Residual Disease in the Clinical Course of T cell Acute Lymphoblastic Leukemia in Pediatric Patients", J Leuk 7 , vol. 7, pp. 256., 2019.
2018
EZ, K., E. S. G, E. N, N. HR, I. D, A. R, H. M, K. M, and Kamel, M.M., "Impact of FLT3 Receptor (CD135) Detection by Flow Cytometry on Clinical Outcome of Adult Acute Myeloid Leukemia Patients", Clin Lymphoma Myeloma Leuk, vol. 18, issue 8, pp. 541-547, 2018.
MS, A., S. SM, E. - H. AH, S. ML, E. - H. ME, and K. EZ, "A novel potential effective strategy for enhancing the antitumor immune response in breast cancer patients using a viable cancer cell-dendritic cell-based vaccine", Oncol Lett., vol. july, issue 16, pp. 529-535, 2018.
2017
S, A. - A., E. S. A. Gaber O, M. D, A. M, K. EZ, and E. I, " FLT3-ITD Mutations in Egyptian Patients of Acute Myeloid Leukemia: Correlation with Cytogenetic, FAB Subgroups and Prognosis", Clin Lab, vol. May(1)63, issue 5, pp. 1027-1034, 2017.
Eissa, D. S., E. Z. Kandeel, and M. Ghareeb, "Human myeloid inhibitory C-lectin: a highly specific and stable acute myeloid leukemia marker.", Hematological oncology, vol. 35, issue 4, pp. 814-820, 2017. hon.2352.pdf
2016
2015
Ramadan, H., E. Kandeel, L. Hegazy, A. Helal, T. Darwish, and S. E. tokhy, "4. Role of Urokinase-Type Plasminogen Activator Receptors as an Early Detector for Treatment Outcome in Adult Acute Myeloid Leukemia in Egyptian Patients", journal of cancer therapy, vol. 6, pp. 963-970, 2015. -8902212_1_saved__2.pdf
2013
Kandeel, E., and A. Kamel, Flow Cytomteric Detection of Minimal Residual Disease Flow Cytomteric Detection of Minimal Residual Disease, , Saarbr├╝cken, LAP Lambert Academic Publishing, 2013. abstract_of_ebook.pdf
2011
Ibrahim, K. M., Shadia Hasan Ragab, N. A. H. E. D. A. B. D. E. L. WAHAB, N. Emara, N. A. Alghafar, E. Kandeel, and A. A. shaymaa Ibrahim, "Circulating Endothelial Cells in Acute Myeloid Leukemia", Australian Journal of Basic and Applied Sciences, vol. 5, issue 11, pp. 1304-1311, 2011.
Tourism